The mouse with a human liver: A new model for the treatment of liver disease

February 22, 2010
Mice whose own liver cells have been replaced with human hepatocytes (shown in green) can be successfully infected with hepatitis B virus (shown in red) providing a new way to test novel therapies for debilitating human liver diseases. Credit: Courtesy of Dr. Karl-Dimiter Bissig, Salk Institute for Biological Studies

How do you study-and try to cure in the laboratory-an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver. This "humanized" mouse is susceptible to human liver infections and responds to human drug treatments, providing a new way to test novel therapies for debilitating human liver diseases and other diseases with liver involvement such as malaria.

"We found that, not only can we infect our humanized mouse with Hepatitis B and , but we can then successfully treat this infection using typical drugs," explains first author Karl-Dimiter Bissig, M.D. Ph.D, an internist and post-doctoral researcher in the Laboratory of Genetics. "As a physician, I understand the importance of this type of bench-to-bedside research. This study shows a real application for our mouse model, making it relevant from both an academic and a clinical perspective."

The Salk researchers' findings will be published in the Feb. 22, 2010 online edition of the .

Host-pathogen specificity is both a blessing and a curse-preventing widespread infection but making successful treatments harder to find. For example, Hepatitis B and Hepatitis C can only infect humans and chimpanzees, and although this species barrier prevents us from being susceptible to every infection out there, the flipside is that finding treatments for human infections can be extremely difficult.

This is particularly true when it comes to liver infections. The usual approach is to grow human cells in a dish, to infect and try to treat them there, but this is not possible with or hepatocytes. "Human hepatocytes are almost impossible to work with as they don't grow and are hard to maintain in culture," explains senior author Inder Verma, Ph.D., a professor in the Laboratory of Genetics and holder of the Irwin and Joan Jacobs Chair in Exemplary Life Science.

And since small animals cannot be infected with Hepatitis C, they cannot be used to test drugs that may cure this disease. What's more, species differences mean that drugs that appear to be effective and non-toxic in animal models sometimes prove to be toxic to humans, and vice versa. Mice whose own hepatocytes have been replaced with human liver cells provide a solution to all these hurdles.

Explains Verma, "This robust model system opens the door to utilize human hepatocytes for purposes that were previously impossible. This chimeric mouse can be used for drug testing and gene therapy purposes, and in the future, may also be used to study liver cancers."

The Salk team had previously generated a mouse with a partially "humanized" liver, but wanted to improve their method to achieve almost complete transformation. They use a special mouse that has liver problems of its own, but whose problems can be kept in check with a drug called NBTC. Taking away NBTC allows human hepatocytes to take hold and populate the mouse liver with human cells.

The team perfected this system so that nearly 95% of the liver cells are of human origin, but the important question was whether they would behave like a human livers. To test this, the researchers exposed the mice to and Hepatitis C and found that, unlike normal mice, which are resistant to these viruses, the chimeric animals developed the disease.

More importantly, using pegylated interferon alpha 2a-the standard treatment for Hepatitis C-the researchers showed that the "humanized" liver inside the mouse responds just like a normal human liver. The team also tested additional experimental drugs and found that they too behaved as they did in humans.

"This shows that our chimeric mouse model is medically relevant and can be used to validate novel drugs in a pre-clinical setting," says Bissig. "This is great news as it provides us with a tool with which we can examine many human hepatotropic pathogens, including malaria. In the future, it also has potential applications for regenerative medicine; allowing confirmation of the true hepatocyte nature of cells prior to human transplantation."

The methodology of generating these mice is freely available to the research community.

Explore further: Researchers turn mouse into factory for human liver cells

Related Stories

Improved culture system for hepatitis C virus infection

July 16, 2008

A University of California, San Diego School of Medicine researcher has developed the first tissue culture of normal, human liver cells that can model infection with the Hepatitis C virus (HCV) and provide a realistic environment ...

Discovery could lead to a new animal model for hepatitis C

January 28, 2009

During its career, the potentially fatal hepatitis C virus has banked its success on a rather unusual strategy: its limitations. Its inability to infect animals other than humans and chimpanzees has severely hampered scientists ...

Keeping hepatitis C virus at bay after a liver transplant

October 1, 2009

One of the most common reasons for needing a liver transplant is liver failure or liver cancer caused by liver cell infection with hepatitis C virus (HCV). However, in nearly all patients the new liver becomes infected with ...

Engineering a new way to study hepatitis C

January 25, 2010

( -- Researchers at MIT and Rockefeller University have successfully grown hepatitis C virus in otherwise healthy liver cells in the laboratory, an advance that could allow scientists to develop and test new treatments ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Cow embryos reveal new type of chromosome chimera

May 27, 2016

I've often wondered what happens between the time an egg is fertilized and the time the ball of cells that it becomes nestles into the uterine lining. It's a period that we know very little about, a black box of developmental ...

Shaving time to test antidotes for nerve agents

February 29, 2016

Imagine you wanted to know how much energy it took to bike up a mountain, but couldn't finish the ride to the peak yourself. So, to get the total energy required, you and a team of friends strap energy meters to your bikes ...


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Feb 22, 2010
That an allow zoonotic diseases to adapt to human physiology easier. Good idea for a narrow problem.. very bad idea overall.
not rated yet Feb 22, 2010
That an allow zoonotic diseases to adapt to human physiology easier. Good idea for a narrow problem.. very bad idea overall.

I think that, since the mice are modified and euthanized in the context of specific research projects, there is little risk. The mice are raised in clean conditions for research so they would not have many pathogens to begin with. What's more, since only the liver is changed, only blood contact would even potentially transfer pathogens and I suspect that researchers already avoid this. It's good to consider possible risks but I don't think there would be a problem here.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.